Advanced search
Publication Cover
Clinical Interventions in Aging Volume 10, 2015 - Issue
Submit an article Journal homepage
77
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Serum total prostate-specific antigen values in men with symptomatic prostate enlargement in Nigeria: role in clinical decision-making

Ikenna I Nnabugwu1 Urology Unit, Department of Surgery, College of Medicine, University of Nigeria, Nsukka, Nigeria;2 Urology Unit, Department of Surgery, Federal Medical Centre, Asaba, NigeriaCorrespondence[email protected]
,
Fred O Ugwumba1 Urology Unit, Department of Surgery, College of Medicine, University of Nigeria, Nsukka, Nigeria
,
Oghenekaro A Enivwenae2 Urology Unit, Department of Surgery, Federal Medical Centre, Asaba, Nigeria
,
Emeka I Udeh1 Urology Unit, Department of Surgery, College of Medicine, University of Nigeria, Nsukka, Nigeria
,
Chris O Otene2 Urology Unit, Department of Surgery, Federal Medical Centre, Asaba, Nigeria
&
Chinwe A Nnabugwu3 Department of Medical Laboratory Services, Federal Medical Centre, Asaba, Nigeria
Pages 89-93 | Published online: 30 Dec 2014

References

  • BadmusTAAdesunkanmiAKYusufBMBurden of prostate cancer in Southwestern NigeriaUrology201076241241620451979
  • National Institute of Clinical ExcellenceProstate cancer diagnosis and treatment Available from: http://www.nice.org.uk/nicemedia/pdf/CG58FullGuideline.pdfAccessed November 24, 2014
  • BensalahKLotanYKaramJAShariatSFNew circulating biomarkers for prostate cancerProstate Cancer Prostatic Dis200811211212017998918
  • WallnerLPMorgensternHMcGreeMEThe effects of body mass index on changes in prostate-specific antigen levels and prostate volume over 15 years of follow-up: implications for prostate cancer detectionCancer Epidemiol Biomarkers Prev201120350150821242331
  • LeeSEHongSKParkHZHigher body mass index is associated with lower risk of prostate cancer detection via multi (≥12)-core prostate biopsy in Korean menUrology20107651063106620573382
  • MoussaASLiJSorianoMKleinEADongFJonesJSProstate biopsy clinical and pathological variables that predict significant grading changes in patients with intermediate and high grade prostate cancerBJU Int20091031434818782303
  • PepePAragonaFIncidence of insignificant prostate cancer using free/total PSA: results of a case-finding protocol on 14,453 patientsProstate Cancer Prostatic Dis201013431631920714341
  • TubaroADe NunzioCMarianiSReduction of prostate-specific antigen after tamsulosin treatment in patients with elevated prostate-specific antigen and lower urinary tract symptoms associated with low incidence of prostate cancer at biopsyUrology201076243644120538320
  • LokuhettyMDWijesingheHDAbeysuriyaDTSamarasingheUCPereraNDTransrectal ultrasound guided prostate biopsies: a single centre experience in Sri LankaCeylon Med J20095416919391448
  • AjapeAAIbrahimKOFakeyeJAAbiolaOOAn overview of cancer of the prostate diagnosis and management in Nigeria: the experience in a Nigerian tertiary hospitalAnn Afr Med20109311311720710099
  • CatalonaWJSmithDSRatliffTLMeasurement of prostate-specific antigen in serum as a screening test for prostate cancerN Engl J Med199132417115611611707140
  • CatalonaWJSmithDSOrnsteinDKProstate cancer detection in men with serum PSA concentrations of 2.6–4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurementsJAMA199727718145214559145717
  • ThompsonIMAnkerstDPChiCOperating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/mL or lowerJAMA20052941667015998892
  • HongSKOhJJByunSImpact of diabetes mellitus on the detection of prostate cancer via contemporary multi (≥12)-core prostate biopsyProstate2012721515721520162
  • AnunobiCCAkindeOREleshaSODaramolaAOTijaniKHOjewolaRWProstate diseases in Lagos, Nigeria: a histologic study with tPSA correlationNiger Postgrad Med J20111829810421670775
  • MettlinCJMurphyGThe national cancer base report on prostate cancerCancer1994745164016488062197
  • BowaKAn overview of the diagnosis and management of prostate cancer in Nigeria: experience from a north-central state of NigeriaAnn Afr Med20109311111220710098
  • OsegbeDNProstate cancer in Nigerians: facts and nonfactsJ Urol19971574134013439120935
  • BowaKKachimbaJSLabibMMudendaVChikwenyaMThe changing pattern of urological cancers in ZambiaMed J Zambia2009354157159
  • MaHWanBRelationship of the positive rate of TRUS guided prostate biopsies with routine diagnostic findings in detecting prostate cancerZhonghua Nan Ke Zue20131914043 Chinese
  • PalmerolaRSmithPElliotVThe digital rectal examination (DRE) remains important – outcomes from a contemporary cohort of men undergoing an initial 12–18 core prostate needle biopsyCan J Urol20121966542654723228289
  • MochtarCAKiemeneyLAvan RiemsdijkMMProstate-specific antigen as an estimator of prostate volume in the management of patients with symptomatic benign prostatic hyperplasiaEur Urol200344669570014644122
  • AbbiyesukuFMShittuOBOduwoleOOOsotimehinBOProstate specific antigen in the Nigerian AfricanAfr J Med Med Sci20002929710011379458
  • SchröderFHRoobolMJDefining the optimal prostate-specific antigen threshold for the diagnosis of prostate cancerCurr Opin Urol200919322723119357513

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.